Joel Greenblatt’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$514K Buy
3,185
+1,178
+59% +$196K ﹤0.01% 1581
2026
Q2
$381K Sell
2,007
-861
-30% -$162K ﹤0.01% 1580
2026
Q1
$566K Buy
2,868
+783
+38% – ﹤0.01% 1461
2025
Q4
$383K Buy
2,085
+716
+52% +$126K ﹤0.01% 1504
2025
Q3
$210K Buy
+1,369
New +$207K ﹤0.01% 1606
2014
Q2
– Sell
-95,518
Closed -$6.2M – 990
2014
Q1
$6.2M Buy
+95,518
New +$6.17M 0.09% 324

Other funds holding AZN

Joel Greenblatt's AZN Position: Q3 2026 in Review

Joel Greenblatt increased its AstraZeneca (AZN) stake by 59% in Q3 2026, buying an estimated $196K and bringing the position to 3,185 shares worth $514K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Joel Greenblatt first reported a position in AZN in Q1 2014 and has held it in 6 quarters since. The position peaked at $6.2M in Q1 2014. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Joel Greenblatt held 3,185 shares of AstraZeneca worth $514K as of Q3 2026.
  • Joel Greenblatt bought 1,178 AstraZeneca shares in Q3 2026, an estimated $196K.
  • AstraZeneca made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1581 holding.
  • Joel Greenblatt first reported a position in AstraZeneca in Q1 2014 and has held it in 6 quarters since.
  • Joel Greenblatt's AstraZeneca position peaked at $6.2M in Q1 2014.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.